Home

Sun Pharma Advanced Research Company Ltd Quarterly Result

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

Net Profit - Last Quarter

₹ -79.51 Cr.

Last updated on: Feb 13, 2025

Sun Pharma Advanced Research Company Ltd Quarterly Results Key Highlights

  • The revenue of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ 15.1 crore as compare to the Sep '24 revenue of ₹ 12.9 crore.
  • This represent the growth of 17.05%a1# The ebitda of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ -73.5 crore as compare to the Sep '24 ebitda of ₹ -102 crore.
  • This represent the decline of -28.55%a1# The net profit of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ -79.51 crore as compare to the Sep '24 net profit of ₹ -107 crore.
  • This represent the decline of -25.92%a1#.

Sun Pharma Advanced Research Company Ltd Quarterly Results Analysis

Market Price of Sun Pharma Advanced Research Company Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Feb 2025146.15
11 Feb 2025150.05
10 Feb 2025156.55
07 Feb 2025158.85
06 Feb 2025159.55
05 Feb 2025160
04 Feb 2025159
03 Feb 2025155.5
01 Feb 2025158.9
31 Jan 2025160.05

Historical Revenue of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Sun Pharma Advanced Research Company Ltd News Hub

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun

Read more

05 Aug 24

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se

Read more

04 Nov 24

Sun Pharma Advanced Research Company to convene board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on

Read more

25 Oct 24

SPARC drops as Q2 net loss widens to Rs 107 crore

Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.

Read more

04 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Sun Pharma Advanced Research Company Ltd

What key financial metrics are included in Sun Pharma Advanced Research Company Ltd's quarterly results?

Key financial metrics in Sun Pharma Advanced Research Company Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Sun Pharma Advanced Research Company Ltd announce its quarterly results?

Sun Pharma Advanced Research Company Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Sun Pharma Advanced Research Company Ltd's quarterly performance impact its stock price?

Sun Pharma Advanced Research Company Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Sun Pharma Advanced Research Company Ltd's quarterly results on dividends?

The impact of Sun Pharma Advanced Research Company Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Sun Pharma Advanced Research Company Ltd's quarterly results?

Yes, Sun Pharma Advanced Research Company Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions